» Articles » PMID: 36454329

International Alliance of Urolithiasis (IAU) Guidelines on the Metabolic Evaluation and Medical Management of Urolithiasis

Abstract

The aim of this study was to construct the fourth in a series of guidelines on the treatment of urolithiasis by the International Alliance of Urolithiasis (IAU) that by providing a clinical framework for the metabolic evaluation, prevention, and follow-up of patients with urolithiasis based on the best available published literature. All recommendations were summarized following a systematic review and assessment of the literature in the PubMed database from January 1976 to June 2022. Each generated recommendation was graded using a modified GRADE methodology. Guideline recommendations were developed that addressed the following topics: initial evaluation, metabolic testing, dietary measures, medical management, and follow-up of recurrent stone formers. It was emphasized by the Panel that prevention of new stone formation is as important as the surgical removal of the stones. Although general preventive measures may be effective in reducing stone recurrence rates in some patients, specific medical and dietary management should be well considered and eventually applied in an individualized manner based on the outcomes of metabolic work-up, stone analysis and some certain patient related factors. A detailed follow-up of each case is essential depending on the metabolic activity of each individual patient.

Citing Articles

A New Perspective on Gas Chromatography-Mass Spectrometry Urinary Metabolomic Analysis and Efficient Risk Assessment of Urolithiasis: Morning Urine Organic Acid Profiles.

Yang J, Zhang D, Lu Y, Mai H, Wu S, Yang Q Kidney Blood Press Res. 2024; 50(1):83-96.

PMID: 39662072 PMC: 11844692. DOI: 10.1159/000542263.


Knowledge, attitude, and practice regarding stone formation and recurrence among urolithiasis patients: a cross-sectional study.

Chen T, Jiang Y, Zhang P, Wang F, Chen B, Yu D Sci Rep. 2024; 14(1):28408.

PMID: 39557990 PMC: 11574188. DOI: 10.1038/s41598-024-80078-x.


International Alliance of Urolithiasis (IAU) guidelines on the management of pediatric urolithiasis.

Zeng G, Zhu W, Somani B, Choong S, Straub M, Maroccolo M Urolithiasis. 2024; 52(1):124.

PMID: 39230669 DOI: 10.1007/s00240-024-01621-z.


Consensus statement addressing controversies and guidelines on pediatric urolithiasis.

Guven S, Tokas T, Tozsin A, Haid B, Lendvay T, Silay S World J Urol. 2024; 42(1):473.

PMID: 39110242 PMC: 11306500. DOI: 10.1007/s00345-024-05161-4.


Cell death‑related molecules and targets in the progression of urolithiasis (Review).

Wu L, Xue X, He C, Lai Y, Tong L Int J Mol Med. 2024; 53(6).

PMID: 38666544 PMC: 11090264. DOI: 10.3892/ijmm.2024.5376.


References
1.
Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L . Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int. 2017; 120(1):109-116. DOI: 10.1111/bju.13828. View

2.
Scales Jr C, Smith A, Hanley J, Saigal C . Prevalence of kidney stones in the United States. Eur Urol. 2012; 62(1):160-5. PMC: 3362665. DOI: 10.1016/j.eururo.2012.03.052. View

3.
Antonelli J, Maalouf N, Pearle M, Lotan Y . Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol. 2014; 66(4):724-9. PMC: 4227394. DOI: 10.1016/j.eururo.2014.06.036. View

4.
Ji G, Zhu F, Xu Q, Wang K, Wu M, Tang W . Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study. EBioMedicine. 2019; 50:156-165. PMC: 6923482. DOI: 10.1016/j.ebiom.2019.10.057. View

5.
Guyatt G, Oxman A, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-6. PMC: 2335261. DOI: 10.1136/bmj.39489.470347.AD. View